Literature DB >> 7748464

Intranigral injected iron progressively reduces striatal dopamine metabolism.

W Wesemann1, S Blaschke, M Solbach, C Grote, H W Clement, P Riederer.   

Abstract

The striatal dopamine metabolism of the rat was followed 1, 3, and 6 weeks after unilateral intranigral iron (III) (50- and 1.5 micrograms) application. For both concentrations a progredient decrease of extraneuronal 3.4-dihydroxyphenylacetic acid (DOPA) levels was observed in the ipsilateral striatum.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7748464     DOI： 10.1007/BF02260941

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN： 0936-3076


  10 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 2.  Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Authors:  Shannon L Rhodes; Beate Ritz
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

3.  Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Authors:  Shannon L Rhodes; Daniel D Buchanan; Ismaïl Ahmed; Kent D Taylor; Marie-Anne Loriot; Janet S Sinsheimer; Jeff M Bronstein; Alexis Elbaz; George D Mellick; Jerome I Rotter; Beate Ritz
Journal:  Neurobiol Dis       Date:  2013-10-08       Impact factor: 5.996

Review 4.  Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

Authors:  M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

5.  MR imaging differentiation of Fe2+ and Fe3+ based on relaxation and magnetic susceptibility properties.

Authors:  Olaf Dietrich; Johannes Levin; Seyed-Ahmad Ahmadi; Annika Plate; Maximilian F Reiser; Kai Bötzel; Armin Giese; Birgit Ertl-Wagner
Journal:  Neuroradiology       Date:  2017-03-21       Impact factor: 2.804

6.  Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats.

Authors:  Mei Liu; Dong-Young Choi; Randy L Hunter; Jignesh D Pandya; Wayne A Cass; Patrick G Sullivan; Hyoung-Chun Kim; Don M Gash; Guoying Bing
Journal:  J Neurochem       Date:  2009-11-17       Impact factor: 5.372

7.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 8.  Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.

Authors:  P Riederer; C Monoranu; S Strobel; T Iordache; J Sian-Hülsmann
Journal:  J Neural Transm (Vienna)       Date:  2021-10-12       Impact factor: 3.575

9.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

10.  Obsessive compulsive disorder comorbidity in DBA.

Authors:  Stefano Pallanti; Sara Masetti; Silvia Bernardi; Alice Innocenti; Mariana Markella; Eric Hollander
Journal:  Clin Pract Epidemiol Ment Health       Date:  2008-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.